D Keizman
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database
Keizman D, Daugaard G, Gillessen Sommer S, Mortensen J, Rouvinov K, Mermershtain W, Sarid D, Dresler H, Gottfried M, Cathomas R, Mueller J, Petersen P, Neiman V, Desax M, Rosenbaum E, Peer A, Reichegger H, Fosboel M, Omlin A. Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database. Prostate Cancer Prostatic Dis 2017; 20:289-293.
28.02.2017Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database
28.02.2017Prostate Cancer Prostatic Dis 2017; 20:289-293
Keizman D, Daugaard G, Gillessen Sommer Silke, Mortensen J, Rouvinov K, Mermershtain W, Sarid D, Dresler H, Gottfried M, Cathomas R, Mueller J, Petersen P M, Neiman V, Desax M-C, Rosenbaum E, Peer A, Reichegger H, Fosboel M O, Omlin Aurelius
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Leibowitz-Amit R, de Bono J, Tannock I, Sridhar S, Knox J, Attard G, Seah J, Vera-Badillo F, Keizman D, Atenafu E, Pezaro C, Omlin A, Templeton A, Joshua A. Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer. Ann Oncol 2014; 25:657-62.
23.01.2014Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
23.01.2014Ann Oncol 2014; 25:657-62
Leibowitz-Amit R, de Bono J S, Tannock I F, Sridhar S S, Knox J J, Attard G, Seah J-A, Vera-Badillo F, Keizman D, Atenafu E G, Pezaro C, Omlin Aurelius, Templeton Arnoud, Joshua A M